The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 11, 2013, Pages 1415-1421

  Pantano, Francesco ^a   Berti, Pierpaolo ^a   Guida, Francesco Maria ^a   Perrone, Giuseppe ^a   Vincenzi, Bruno ^a   Amato, Michelina Maria Carla ^a   Righi, Daniela ^a   Dell'Aquila, Emanuela ^a   Graziano, Francesco ^b   Catalano, Vincenzo ^b   Caricato, Marco ^a   Rizzo, Sergio ^c   Muda, Andrea Onetti ^a   Russo, Antonio ^c   Tonini, Giuseppe ^a   Santini, Daniele ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Gastric cancer; M1 polarization; M2 polarization; Prognostic factor; Tumour associated macrophages

Indexed keywords

ARTICLE; CELL POLARITY; FEMALE; GASTRECTOMY; HUMAN; IMMUNOLOGY; KAPLAN MEIER METHOD; M1 POLARIZATION; M2 POLARIZATION; MACROPHAGE; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; PROGNOSIS; PROGNOSTIC FACTOR; RETROSPECTIVE STUDY; STOMACH CANCER; STOMACH TUMOR; TREATMENT OUTCOME; TUMOUR ASSOCIATED MACROPHAGES;

GASTRIC CANCER; M1 POLARIZATION; M2 POLARIZATION; PROGNOSTIC FACTOR; TUMOUR ASSOCIATED MACROPHAGES;

CELL POLARITY; FEMALE; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; MACROPHAGES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84891153305     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12109     Document Type: Article

References (44)

1. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol. 2002; 196: 254-65.
2. Andreu P, Johansson M, Affara NI, et al. FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell. 2010; 17: 121-34.
3. de Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell. 2005; 7: 411-23.
4. Nardin A, Abastado JP. Macrophages and cancer. Front Biosci. 2008; 13: 3494-505.
5. + immature myeloid cells. Nat Med. 2011; 17: 87-95.
6. Sierra JR, Corso S, Caione L, et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med. 2008; 205: 1673-85.
7. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003; 3: 23-35.
8. Solinas G, Germano G, Mantovani A, et al. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol. 2009; 86: 1065-73.
9. Mantovani A, Sica A, Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol. 2007; 37: 14-6.
10. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity. 2005; 23: 344-6.
11. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, et al. Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett. 2007; 113: 76-82.
12. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated acrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23: 549-55.
13. Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010; 22: 231-7.
14. Mantovani A, Sica A, Allavena P, et al. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum Immunol. 2009; 70: 325-30.
15. Ohta M, Kitadai Y, Tanaka S, et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol. 2003; 22: 773-8.
16. Ishigami S, Natsugoe S, Tokuda K, et al. Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res. 2003; 23: 4079-83.
17. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. Lyon, France: IARC Press, International Agency for Research on Cancer; 2010.
18. Sobin LH, Gospodarowicz MK, Wittekind C, eds. TNM classification of malignant tumours. 7th ed. Weinheim, Germany: Wiley; 2009. pp. 19-20.
19. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977; 35: 1-39.
20. Ohri CM, Shikotra A, Green RH, et al. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J. 2009; 33: 118-26.
21. Ma J, Liu L, Che G, et al. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer. 2010; 10: 112.
22. Schmieder A, Michel J, Schonhaar K, et al. Differentiation and gene expression profile of tumor-associated macrophages. Semin Cancer Biol. 2012; 22: 289-97.
23. Sica A, Larghi P, Mancino A, et al. Macrophage polarization in tumour progression. Semin Cancer Biol. 2008; 18: 349-55.
24. Song L, Asgharzadeh S, Salo J, et al. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J Clin Invest. 2009; 119: 1524-36.
25. Jensen TO, Schmidt H, Moller HJ, et al. Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. J Clin Oncol. 2009; 27: 3330-7.
26. Kurahara H, Shinchi H, Mataki Y, et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res. 2011; 167: 211-9.
27. Welsh TJ, Green RH, Richardson D, et al. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol. 2005; 23: 8959-67.
28. Kataki A, Scheid P, Piet M, et al. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab Clin Med. 2002; 140: 320-8.
29. Balkwill F, Mantovani A. Inflammation and cancer: back to virchow? Lancet. 2001; 357: 539-45.
30. Barbera-Guillem E, Nyhus JK, Wolford CC, et al. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res. 2002; 62: 7042-9.
31. Shabo I, Stal O, Olsson H, et al. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer. 2008; 123: 780-6.
32. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009; 27: 451-83.
33. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8: 958-69.
34. Ohri CM, Shikotra A, Green RH, et al. The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC. PLoS ONE. 2011; 6: e21874.
35. Moestrup SK, Moller HJ. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med. 2004; 36: 347-54.
36. Stout RD, Jiang C, Matta B, et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol. 2005; 175: 342-9.
37. Foukas PG, Tsilivakos V, Zacharatos P, et al. Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs) and regional lymph nodes of non-small-cell lung carcinomas. A putative mechanism of tumor-induced immunosuppression? Anticancer Res. 2001; 21: 2609-15.
38. Puhakka A, Kinnula V, Napankangas U, et al. High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma. APMIS. 2003; 111: 1137-46.
39. Tran TA, Kallakury BV, Ambros RA, et al. Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma. Cancer. 1998; 83: 276-82.
40. Binion DG, Fu S, Ramanujam KS, et al. iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol. 1998; 275: G592-603.
41. Luoma JS, Stralin P, Marklund SL, et al. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 1998; 18: 157-67.
42. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355: 11-20.
43. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the mrc randomised controlled surgical trial. The surgical cooperative group. Lancet. 1996; 347: 995-9.
44. Ohno S, Inagawa H, Dhar DK, et al. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack. Anticancer Res. 2005; 25: 463-70.